Global Bio Similars Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Bio Similars market size will reach 10,155 Million USD in 2025 and is projected to reach 29,954 Million USD by 2032, with a CAGR of 16.71% (2025-2032). Notably, the China Bio Similars market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Bio similars, also known as biosimilars or follow-on biologics, are pharmaceutical products that are highly similar to an already approved reference biological product (also known as the originator or reference product). These bio similars are developed to be highly similar in terms of quality, efficacy, and safety to the reference product. However, unlike generic versions of small-molecule drugs, which are identical copies of their reference products, bio similars are not exact replicas due to the complexity of biological molecules. Bio similars undergo a rigorous process of development and testing to demonstrate similarity to the reference product, ensuring that they are effective and safe for use. They are often used as more affordable alternatives to the reference product, providing increased access to important treatments and promoting competition in the biopharmaceutical market.
The major global suppliers of Bio Similars include Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck, Biogen idec, Genentech (Roche), Pfizer, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy＇s Laboratories, Stada Arzneimittel, AbbVie, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly, Novartis, 3sbio, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Bio Similars. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Bio Similars market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Bio Similars market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bio Similars industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Bio Similars Include:
Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy＇s Laboratories
Stada Arzneimittel
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Bio Similars Product Segment Include:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Bio Similars Product Application Include:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Bio Similars Industry PESTEL Analysis
Chapter 3: Global Bio Similars Industry Porter's Five Forces Analysis
Chapter 4: Global Bio Similars Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Bio Similars Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Bio Similars Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Bio Similars Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Bio Similars market size will reach 10,155 Million USD in 2025 and is projected to reach 29,954 Million USD by 2032, with a CAGR of 16.71% (2025-2032). Notably, the China Bio Similars market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Bio similars, also known as biosimilars or follow-on biologics, are pharmaceutical products that are highly similar to an already approved reference biological product (also known as the originator or reference product). These bio similars are developed to be highly similar in terms of quality, efficacy, and safety to the reference product. However, unlike generic versions of small-molecule drugs, which are identical copies of their reference products, bio similars are not exact replicas due to the complexity of biological molecules. Bio similars undergo a rigorous process of development and testing to demonstrate similarity to the reference product, ensuring that they are effective and safe for use. They are often used as more affordable alternatives to the reference product, providing increased access to important treatments and promoting competition in the biopharmaceutical market.
The major global suppliers of Bio Similars include Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck, Biogen idec, Genentech (Roche), Pfizer, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy＇s Laboratories, Stada Arzneimittel, AbbVie, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly, Novartis, 3sbio, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Bio Similars. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Bio Similars market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Bio Similars market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bio Similars industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Bio Similars Include:
Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy＇s Laboratories
Stada Arzneimittel
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Bio Similars Product Segment Include:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Bio Similars Product Application Include:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Bio Similars Industry PESTEL Analysis
Chapter 3: Global Bio Similars Industry Porter's Five Forces Analysis
Chapter 4: Global Bio Similars Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Bio Similars Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Bio Similars Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Bio Similars Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Bio Similars Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Bio Similars Product by Type
- 1.2.1 Monoclonal Antibodies
- 1.2.2 Interferon
- 1.2.3 Erythropoietin
- 1.2.4 Insulin
- 1.2.5 Vaccines
- 1.2.6 Other
- 1.3 Bio Similars Product by Application
- 1.3.1 Tumor
- 1.3.2 Diabetes
- 1.3.3 Cardiovascular
- 1.3.4 Hemophilia
- 1.3.5 Other
- 1.4 Global Bio Similars Market Size Analysis (2020-2032)
- 1.5 Bio Similars Market Development Status and Trends
- 1.5.1 Bio Similars Industry Development Status Analysis
- 1.5.2 Bio Similars Industry Development Trends Analysis
- 2 Bio Similars Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Bio Similars Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Bio Similars Market Analysis by Country
- 4.1 Global Bio Similars Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Bio Similars Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Bio Similars Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.5 China Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.6 France Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.14 India Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Bio Similars Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Bio Similars Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Bio Similars Market Revenue by Key Suppliers (2021-2025)
- 5.2 Bio Similars Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Bio Similars Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Bio Similars Market Analysis by Type
- 6.1 Global Bio Similars Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Bio Similars Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sun Pharma
- 7.1.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sun Pharma Bio Similars Product Portfolio
- 7.1.3 Sun Pharma Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Synthon Pharmaceuticals
- 7.2.1 Synthon Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Synthon Pharmaceuticals Bio Similars Product Portfolio
- 7.2.3 Synthon Pharmaceuticals Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Teva Pharmaceutical Industries
- 7.3.1 Teva Pharmaceutical Industries Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Teva Pharmaceutical Industries Bio Similars Product Portfolio
- 7.3.3 Teva Pharmaceutical Industries Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 LG Life Sciences
- 7.4.1 LG Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 LG Life Sciences Bio Similars Product Portfolio
- 7.4.3 LG Life Sciences Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Celltrion Biocon
- 7.5.1 Celltrion Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Celltrion Biocon Bio Similars Product Portfolio
- 7.5.3 Celltrion Biocon Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Hospira
- 7.6.1 Hospira Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Hospira Bio Similars Product Portfolio
- 7.6.3 Hospira Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Merck
- 7.7.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Merck Bio Similars Product Portfolio
- 7.7.3 Merck Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Biogen idec
- 7.8.1 Biogen idec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Biogen idec Bio Similars Product Portfolio
- 7.8.3 Biogen idec Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Genentech (Roche)
- 7.9.1 Genentech (Roche) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Genentech (Roche) Bio Similars Product Portfolio
- 7.9.3 Genentech (Roche) Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Pfizer
- 7.10.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Pfizer Bio Similars Product Portfolio
- 7.10.3 Pfizer Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Celltrion
- 7.11.1 Celltrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Celltrion Bio Similars Product Portfolio
- 7.11.3 Celltrion Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Biocon
- 7.12.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Biocon Bio Similars Product Portfolio
- 7.12.3 Biocon Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Amgen
- 7.13.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Amgen Bio Similars Product Portfolio
- 7.13.3 Amgen Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Samsung Biologics
- 7.14.1 Samsung Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Samsung Biologics Bio Similars Product Portfolio
- 7.14.3 Samsung Biologics Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Mylan
- 7.15.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Mylan Bio Similars Product Portfolio
- 7.15.3 Mylan Bio Similars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 Dr. Reddy＇s Laboratories
- 7.16.1 Dr. Reddy＇s Laboratories Basic Company Profile (Employees, Areas S
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
